eGenesis
6 known investors
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
Founders & leadership
MC
Mike Curtis, Ph.D.President & Chief Executive Officer